Heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries: an
evidence-based approach to a clinical pro Page 1 282 J can chir, Vol. 45, No 4, août 2002 © …

Objective To investigate the safety and effectiveness of low molecular weight heparin
(LMWH) in preventing deep venous thrombosis (DVT) in high-risk trauma patients …

One hundred consecutive patients with multiple trauma, who were admitted to a level I
trauma center with an injury severity score of 10 or greater, were studied prospectively. A …

Assesses the efficacy of deep venous thrombosis (DVT) prophylaxis in the treatment of
trauma patients. Conflict among previous studies on the impact of prophylactic anticoagulant …

Deep venous thrombosis prophylaxis is essential to the appropriate management of
multisystem trauma patients. Without thromboprophylaxis, the rate of venous thrombosis and …

Background: Deep venous thrombosis (DVT) in severely injured patients is a life-threatening
complication. Effective and safe thromboprophylaxis is highly desirable to prevent DVT. Low …

Introduction Venous thromboembolism is a preventable cause of death in the severely
injured patient. Low-molecular-weight heparins (LMWHs) have been recommended as …

Venous thromboembolic disease is a significant source of morbidity and mortality in
hospitalized trauma patients. Multiple drugs and dosing regimens have been suggested for …

Abstract Background In trauma patients, Enoxaparin (a low molecular weight heparin,
LMWH) prophylaxis for venous thromboembolism (VTE) risk reduction is unproven. Methods …

The incidence of deep venous thrombosis (DVT) and the efficacy of prophylactic measures
were prospectively evaluated in all patients admitted to a level I trauma center during 1991 …